Status:
COMPLETED
Biomarker for Rapid Diagnosis of Hemispheric Stroke
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Acute Stroke
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to estimate the diagnostic accuracy of a combined biomarker test (including NMDA-Receptor fragments \[NR2-peptide\] and Glial fibrillary acidic protein) used to differentiate b...
Eligibility Criteria
Inclusion
- hemiparesis
- at least one sign of cortical involvement (e.g., aphasia, neglect, gaze deviation, reduced level of consciousness)
- hospital admission within 4.5 hours after symptom onset
Exclusion
- stroke/TIA within the last 3 months
- traumatic brain injury within the last 3 months
- history of brain tumor
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00916864
Start Date
June 1 2009
End Date
June 1 2011
Last Update
June 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, Goethe-University
Frankfurt am Main, Germany, 60590